The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
Bernhard Mlecnik1, Gabriela Bindea1, Amos Kirilovsky1
1INSERM, UMRS1138, Laboratory of Integrative Cancer Immunology, F-75006 Paris, France. Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, F-75006 Paris, France. Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, F-75006 Paris, France.
Abstract:
Although distant metastases account for most of the deaths in cancer patients, fundamental questions regarding mechanisms that promote or inhibit metastasis remain unanswered. We show the impact of mutations, genomic instability, lymphatic and blood vascularization, and the immune contexture of the tumor microenvironment on synchronous metastases in large cohorts of colorectal cancer patients. We observed large genetic heterogeneity among primary tumors, but no major differences in chromosomal instability or key cancer-associated mutations. Similar patterns of cancer-related gene expression levels were observed between patients. No cancer-associated genes or pathways were associated with M stage. Instead, mutations of FBXW7 were associated with the absence of metastasis and correlated with increased expression of T cell proliferation and antigen presentation functions. Analyzing the tumor microenvironment, we observed two hallmarks of the metastatic process: decreased presence of lymphatic vessels and reduced immune cytotoxicity. These events could be the initiating factors driving both synchronous and metachronous metastases. Our data demonstrate the protective impact of the Immunoscore, a cytotoxic immune signature, and increased marginal lymphatic vessels, against the generation of distant metastases, regardless of genomic instability.
Insights
Mutations in FBXW7 and a robust immune response protect against colorectal cancer metastasis. Increased lymphatic vessels also reduce distant spread, highlighting immune contexture and vascularization as key factors.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- Distant metastases are the primary cause of cancer-related deaths, yet the mechanisms driving or inhibiting this process remain unclear.
- Understanding metastasis is crucial for improving patient outcomes in colorectal cancer (CRC).
Purpose of the Study:
- To investigate the impact of genetic mutations, genomic instability, vascularization, and the tumor immune microenvironment on synchronous metastasis in colorectal cancer.
- To identify key factors that promote or inhibit the development of distant metastases.
Main Methods:
- Analysis of large cohorts of colorectal cancer patients.
- Assessment of tumor genetic heterogeneity, chromosomal instability, cancer-associated mutations, and gene expression.
- Evaluation of lymphatic and blood vascularization, and immune cell infiltration (Immunoscore).
Main Results:
- No significant association found between genomic instability or key mutations and metastasis stage (M stage).
- FBXW7 mutations correlated with an absence of metastasis and enhanced T cell activity.
- Decreased lymphatic vessels and reduced immune cytotoxicity were identified as hallmarks of the metastatic process.
- The Immunoscore and increased marginal lymphatic vessels demonstrated a protective effect against distant metastases.
Conclusions:
- Tumor microenvironment factors, specifically immune cytotoxicity and lymphatic vessel presence, are critical in preventing colorectal cancer metastasis.
- FBXW7 mutations may confer a protective role against metastasis by modulating the immune response.
- Genomic instability does not appear to be a primary driver of synchronous metastasis in this CRC cohort.
More Related Videos
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
